Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Alcohol Dependence in Very Heavy Drinkers
NCT01146613Phase 2Completed
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Feb 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of varenicline in alcohol dependence (2 arms), sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoint: Weekly Percentage of Heavy Drinking Days. Started Feb 2011; status: completed.
02
Drugs
varenicline
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01146613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146613.